Close Menu

Natera

NEW YORK (GenomeWeb News) – Natera and Unilabs have struck an agreement under which Unilabs will distribute Natera's non-invasive prenatal screening test, Panorama, in Switzerland and Scandinavia, the companies said today.

With the launch of its noninvasive sequencing-based prenatal aneuploidy test in March, Natera became the latest company to enter the highly competitive space, which includes first-comer Sequenom, Illumina-owned Verinata Health, and Ariosa Diagnostics.

The burgeoning market for noninvasive prenatal testing has to date been dominated by next-generation sequencing-based offerings, but that may change next year when CellScape launches its Clarity test.

NEW YORK (GenomeWeb News) – Looking to enter the fast-growing non-invasive prenatal diagnostics space, CellScape is eyeing a second-half 2014 commercial launch of its test, which detects for fetal aneuploidies, and more importantly, genetic disorders that currently require invasive methods for de

NEW YORK (GenomeWeb News) – The prenatal genetic testing firm Natera said today that it has signed up Echevarne, a clinical analysis lab based in Barcelona, to offer its non-invasive prenatal screening test for chromosomal abnormalities to customers in Spain.

This story was originally published May 10.

Aviir has launched two comprehensive genetic panels to test for undiagnosed arrhythmia or cardiomyopathy. The tests cover the major causes of cardiomyopathies, arrhythmia disorders, and other genetically transmitted diseases that affect the heart and vasculature.

COLD SPRING HARBOR, NY (GenomeWeb News) – At an ethical, legal, and social implications, or ELSI, panel at the Biology of Genomes meeting here yesterday, a panel of ethicists, researchers, and legal experts mulled over some of the key ethical issues surrounding prenatal genetic testing — particul

Sequencing of maternal plasma to detect fetal chromosomal aneuploidies is currently being offered by four US-based companies — Sequenom, Verinata Health, Ariosa Diagnostics, and Natera — and researchers now think that the technique can be expanded to detect sub-chromosomal deleti

NEW YORK (GenomeWeb News) – Noninvasive prenatal test developer Natera has completed a $54.6 million financing round to support its expansion and the rollout of its sequencing-based fetal aneuploidy test called Panorama.

Pages

The editorial board of the Pittsburgh Post-Gazette says other lawmakers should take Florida's approach and provide additional protections against genetic discrimination.

The Hill reports 17 states and the District of Columbia are suing over a new policy that would strip international students of their visas if they only attend classes online.

Centers for Disease Control and Prevention employees call on the agency to label racism a public health crisis and examine its own policies, NPR reports.

In PNAS this week: genetic evidence for Inca resettlement, analysis of spermatogonial stem cell transcriptomes, and more.